chronic periodontitis. Chronic pericoronitis Periodontitis: NOS complex simplex
Conditions
Interventions
Intervention 1: chart completion, scaling and brushing by handheld devices, ultrasonic and Rabrkp and paste pumice in treatment during, injected the chlorhexidin within gingiva. Intervention 2: chart
Treatment - Drugs
chart completion, scaling and brushing by handheld devices, ultrasonic and Rabrkp and paste pumice in treatment during, injected the chlorhexidin within gingiva
chart completion, scaling and brushing by handheld devices, ultrasonic and Rabrkp and paste pumice
Sponsors
Vice Chancellor for research of Tabriz University of Medical Sciences, School of Dentistry, Tabriz,
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: presence of type 2 diabetes ; HbA1c = 6.0% ; Clinical Diagnosis of moderate generalized chronic periodontists defined by loss of clinical attachment more than 3mm and bone loss more than 30% ; Presence of more than 10 teeth per dental arch, excluding third molars ; No previous periodontal treatment taken ; signing informed consent, and commitment to post treatment follow-up visits ; no modification in medication for two months, before or during the study exclusion criteria: Presence of systemic disease that could influence the course of periodontal disease ; Intake of anti-inflammatory antibiotics for four weeks before the study ; current smokers or ex-smokers of <5 years ; Pregnancy or intention to be pregnant during the six months of study ; Intake of periodontal treatment in 3 months ago ;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c. Timepoint: Before the experiment, three months after the intervention, six months after the intervention. Method of measurement: Examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fast Blood Sugur (FBS). Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: Examination.;Clinical attachment level (CAL). Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: with periodontal prob from CEJ to pocket depth.;Probing depth (PD). Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: with periodontal prob.;Plaque Index. Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: Disclosing tablets.;Bleeding Index (BI). Timepoint: Befoer the experiment (Baseline) , 3 months after the intervention, 6 month after the intervention. Method of measurement: observe. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Masoumeh Faramarzi
Gum disease and tooth Research Center, School of Dentistry, Tabriz
Outcome results
None listed